1-3 of 3
Authors: John J. Wright
Journal Article
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas Get access
Neuro-Oncology, Volume 16, Issue 5, May 2014, Pages 707–718, https://doi.org/10.1093/neuonc/nou004
Published: 04 February 2014
Journal Article
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02 Get access
Neuro-Oncology, Volume 16, Issue 4, April 2014, Pages 567–578, https://doi.org/10.1093/neuonc/not247
Published: 26 January 2014
Journal Article
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02 Get access
Neuro-Oncology, Volume 14, Issue 12, December 2012, Pages 1511–1518, https://doi.org/10.1093/neuonc/nos264
Published: 24 October 2012
